Volume 13, Number 9—September 2007
Dispatch
New Clinicoepidemiologic Profile of Cutaneous Leishmaniasis, Morocco
Mohamed Rhajaoui*1, Abedelmajeed Nasereddin†1
, Hajiba Fellah*, Kifaya Azmi†, Fatima Amarir*, Amer Al-Jawabreh†, Suheir Ereqat†, Joseph Planer‡, and Ziad Abdeen†
, Hajiba Fellah*, Kifaya Azmi†, Fatima Amarir*, Amer Al-Jawabreh†, Suheir Ereqat†, Joseph Planer‡, and Ziad Abdeen†
Figure 2
Figure 2. Comparison between endonuclease BsuRI digestion patterns of internal transcribed spacer 1–PCR products from clinical samples and reference Leishmania strains. Clinical samples, lanes 1–6: lane 1, Boulmane; lane 2, Ouarzazate; lanes 3–6, Sidi Kacem. Reference strains, lanes 7–9: lane 7, L. tropica (MHOM/SU/1974/SAF-K27); lane 8, L. major (MHOM/TM/1973/5ASKH); lane 9, L. infantum (MHOM/TN/1980/IPT1). MW, DNA molecular weight marker in base pairs (bp).
Page created: July 01, 2010
Page updated: July 01, 2010
Page reviewed: July 01, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
Content Credential
